OpenBilldrug price receipt

NADAC week of 2026-10-14

AMLODIPINE-ATORVAST 5-10 MG

For 30 tablets

Pharmacies pay

$32.43 filed

30 × $1.08105 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$70.80 filed

30 × $2.36005 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

2.2× estimated

Medicare paid 2.2× what pharmacies pay.

Part D averages every strength and form sold under “Amlodipine-Atorvastatin” / “Amlodipine/Atorvastatin” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$42.29 estimated

$32.43 + $4.86 (15%) + $5.00 fee per fill = $42.29

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

AMLODIPINE-ATORVAST 5-10 MG is how the CMS NADAC file names this product. The FDA NDC Directory lists it as amlodipine and atorvastatin.

FDA gives its dosage form as “tablet, film coated” and “tablet, coated” and its route as oral.

FDA lists 4 labelers (the companies named on the label) for its NDCs, among them Mylan Pharmaceuticals Inc., Apotex Corp. and Alembic Pharmaceuticals Inc.

FDA lists it under 3 Established Pharmacologic Classes: Calcium Channel Blocker, Dihydropyridine Calcium Channel Blocker and HMG-CoA Reductase Inhibitor.

The NADAC file of 2026-10-14 prices it under 4 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $32.43 for 30 tablets (30 × $1.08105 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

All 4 NDCs

Other strengths, forms and brands

10 other products in the NADAC file share the FDA nonproprietary name amlodipine and atorvastatin with AMLODIPINE-ATORVAST 5-10 MG.

ProductPharmacies pay per unitMedicare per unit
AMLODIPINE-ATORVAST 2.5-10 MG
generic · tablet, film coated / tablet, coated
$3.07993 per EA filed
eff. 2026-08-19
$2.36005 per EA filed
Part D 2024 average
AMLODIPINE-ATORVAST 2.5-20 MG
generic · tablet, film coated / tablet, coated
$4.49673 per EA filed
eff. 2026-04-22
$2.36005 per EA filed
Part D 2024 average
AMLODIPINE-ATORVAST 2.5-40 MG
generic · tablet, film coated / tablet, coated
$5.0363 per EA filed
eff. 2026-09-23
$2.36005 per EA filed
Part D 2024 average
AMLODIPINE-ATORVAST 5-10 MG this page
generic · tablet, film coated / tablet, coated
$1.08105 per EA filed
eff. 2026-09-23
$2.36005 per EA filed
Part D 2024 average
AMLODIPINE-ATORVAST 5-20 MG
generic · tablet, film coated / tablet, coated
$0.88094 per EA filed
eff. 2026-09-23
$2.36005 per EA filed
Part D 2024 average
AMLODIPINE-ATORVAST 5-40 MG
generic · tablet, film coated / tablet, coated
$1.19146 per EA filed
eff. 2026-09-23
$2.36005 per EA filed
Part D 2024 average
AMLODIPINE-ATORVAST 5-80 MG
generic · tablet, film coated / tablet, coated
$1.55758 per EA filed
eff. 2026-09-23
$2.36005 per EA filed
Part D 2024 average
AMLODIPINE-ATORVAST 10-10 MG
generic · tablet, film coated / tablet, coated
$0.97947 per EA filed
eff. 2026-09-23
$2.36005 per EA filed
Part D 2024 average
AMLODIPINE-ATORVAST 10-20 MG
generic · tablet, film coated / tablet, coated
$0.79702 per EA filed
eff. 2026-09-23
$2.36005 per EA filed
Part D 2024 average
AMLODIPINE-ATORVAST 10-40 MG
generic · tablet, film coated / tablet, coated
$1.33627 per EA filed
eff. 2026-09-23
$2.36005 per EA filed
Part D 2024 average
AMLODIPINE-ATORVAST 10-80 MG
generic · tablet, film coated / tablet, coated
$1.56509 per EA filed
eff. 2026-09-23
$2.36005 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-04-22, 2026-08-19, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 4 NDCs’ NADAC prices is $1.08105 per EA filed.

Of the 107 other products in FDA’s Calcium Channel Blocker class priced per EA, 48 have a higher middle NADAC price and 59 a lower one. The one in the middle is OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-5-25 MG, at $0.99481 per EA filed (eff. 2026-09-23).

Of the 67 other products in FDA’s Dihydropyridine Calcium Channel Blocker class priced per EA, 35 have a higher middle NADAC price and 32 a lower one. The one in the middle is ISRADIPINE 2.5 MG CAPSULE, at $1.13676 per EA filed (eff. 2026-09-23).

Of the 56 other products in FDA’s HMG-CoA Reductase Inhibitor class priced per EA, 26 have a higher middle NADAC price and 30 a lower one. The one in the middle is PITAVASTATIN 2 MG TABLET, at $0.95425 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $70.80 for 30 tablets, at an average of $2.36005 per EA in 2024 (2024-01-01 to 2024-12-31) for “Amlodipine-Atorvastatin” and “Amlodipine/Atorvastatin”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 104,801 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for AMLODIPINE-ATORVAST 5-10 MG labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Amlodipine-Atorvastatin / Amlodipine/Atorvastatin: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.